| ID Source | ID |
|---|---|
| PubMed CID | 137888 |
| SCHEMBL ID | 11843487 |
| MeSH ID | M0465018 |
| Synonym |
|---|
| 2,3-diazabicyclo(2.2.2)oct-2-ene |
| 3310-62-1 |
| 2,3-diazabicyclo[2.2.2]oct-2-ene |
| SCHEMBL11843487 |
| JOHCCHGNXMXHPU-UHFFFAOYSA-N |
| DTXSID70186769 |
| 3,6-ethano-3,4,5,6-tetrahydropyridazine |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.87) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||